Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects

Sirolimus (SRL) and everolimus (EVR) are mammalian targets of rapamycin inhibitors (mTOR-I) largely employed in renal transplantation and oncology as immunosuppressive/antiproliferative agents. SRL was the first mTOR-I produced by the bacterium Streptomyces hygroscopicus and approved for several med...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Simona, Dalla Gassa, Alessandra, Carraro, Amedeo, Brunelli, Matteo, Stallone, Giovanni, Lupo, Antonio, Zaza, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881557/
https://www.ncbi.nlm.nih.gov/pubmed/27187382
http://dx.doi.org/10.3390/ijms17050735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881557/
https://www.ncbi.nlm.nih.gov/pubmed/27187382
http://dx.doi.org/10.3390/ijms17050735

Ejemplares similares